NRX Pharmaceuticals, Inc. Investing Cash Flow
NRX Pharmaceuticals, Inc. (NRXP) reported Investing Cash Flow of -$897.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- NRX Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$684.00K.
- NRX Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$213.00K.
- NRX Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$249.00K.
- NRX Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$2.56M.
- NRX Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$2.81M.
- NRX Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $0.00.
- NRX Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$3.00K.
- NRX Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$10.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$684.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$897.00K 10-Q · filed 2026-08-14 | -$1.15M derived: sum of 3 quarters · filed 2026-08-14 | -$3.71M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$213.00K 10-Q · filed 2026-05-15 | -$462.00K derived: sum of 2 quarters · filed 2026-05-15 | -$3.02M derived: sum of 3 quarters · filed 2026-05-15 | -$3.02M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$2.81M derived: sum of 2 quarters · filed 2026-03-23 | -$2.81M derived: sum of 3 quarters · filed 2026-08-14 | -$2.81M 10-K · filed 2026-03-23 | |||
| 2025-09-30 | -$2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.56M derived: sum of 2 quarters · filed 2026-08-14 | -$2.56M 10-Q · filed 2025-11-14 | -$2.56M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 derived: sum of 3 quarters · filed 2026-05-15 | $0.00 derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | $0.00 derived: sum of 3 quarters · filed 2026-03-23 | $0.00 10-K · filed 2026-03-23 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | $1.00K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $1.00K derived: sum of 3 quarters · filed 2025-05-15 | -$1.00K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | $1.00K derived: sum of 2 quarters · filed 2025-05-15 | -$1.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.00K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$1.00K derived: sum of 2 quarters · filed 2025-03-14 | $1.00K derived: sum of 3 quarters · filed 2025-03-14 | -$3.00K 10-K · filed 2025-03-14 | |||
| 2023-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | -$4.00K 10-Q · filed 2024-11-14 | -$3.00K derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$2.00K 10-Q · filed 2024-08-14 | -$1.00K derived: sum of 3 quarters · filed 2024-08-14 | -$6.00K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$4.00K 10-Q · filed 2024-05-14 | -$3.00K derived: sum of 2 quarters · filed 2024-05-14 | -$8.00K derived: sum of 3 quarters · filed 2024-05-14 | -$11.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$4.00K derived: sum of 2 quarters · filed 2024-03-29 | -$7.00K derived: sum of 3 quarters · filed 2024-03-29 | -$10.00K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$8.00K derived: sum of 2 quarters · filed 2023-11-14 | -$11.00K 10-Q · filed 2023-11-14 | -$11.00K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$6.00K 10-Q · filed 2023-08-14 | -$6.00K derived: sum of 3 quarters · filed 2023-08-14 | -$10.00K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | -$3.00K 10-Q · filed 2023-05-15 | -$3.00K derived: sum of 2 quarters · filed 2023-05-15 | -$7.00K derived: sum of 3 quarters · filed 2023-05-15 | -$10.00K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$4.00K derived: sum of 2 quarters · filed 2023-03-31 | -$7.00K derived: sum of 3 quarters · filed 2023-03-31 | -$7.00K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$7.00K derived: sum of 2 quarters · filed 2022-11-14 | -$7.00K 10-Q · filed 2022-11-14 | -$6.61K 10-Q · filed 2021-11-15 | -$26.22M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$3.00K 10-Q · filed 2022-08-15 | -$2.78K 10-Q · filed 2021-08-16 | -$26.21M derived: sum of 3 quarters · filed 2022-08-15 | -$25.91M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-21 | -$26.21M derived: sum of 2 quarters · filed 2022-03-31 | -$25.91M derived: sum of 3 quarters · filed 2022-03-31 | -$25.93M derived: sum of 4 quarters · filed 2022-03-31 | |||
| 2020-12-31 | -$26.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$25.91M derived: sum of 2 quarters · filed 2022-03-31 | -$25.93M derived: sum of 3 quarters · filed 2022-03-31 | -$2.00K 10-K · filed 2022-03-31 | $26.18M 10-K · filed 2021-04-01 | ||
| 2020-09-30 | $306.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $282.91K derived: sum of 2 quarters · filed 2020-11-16 | $26.21M 10-Q · filed 2020-11-16 | $35.85M derived: sum of 4 quarters · filed 2021-05-21 | |||
| 2020-06-30 | -$23.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $25.90M 10-Q · filed 2020-08-14 | $35.55M derived: sum of 3 quarters · filed 2021-05-21 | $44.48M derived: sum of 4 quarters · filed 2021-05-21 | |||
| 2020-03-31 | $25.93M 10-Q · filed 2021-05-21 | $35.57M derived: sum of 2 quarters · filed 2021-05-21 | $44.50M derived: sum of 3 quarters · filed 2021-05-21 | $66.68M derived: sum of 4 quarters · filed 2021-05-21 | |||
| 2019-12-31 | $9.64M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-14 | $18.58M derived: sum of 2 quarters · filed 2021-05-14 | $40.75M derived: sum of 3 quarters · filed 2021-05-14 | $40.25M 10-K/A · filed 2021-05-14 | |||
| 2019-09-30 | $8.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $31.11M derived: sum of 2 quarters · filed 2020-11-16 | $30.60M 10-Q · filed 2020-11-16 | $29.92M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | $22.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $21.67M 10-Q · filed 2020-08-14 | $20.99M derived: sum of 3 quarters · filed 2020-08-14 | $20.99M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | -$508.21K 10-Q · filed 2020-05-15 | -$1.19M derived: sum of 2 quarters · filed 2020-05-15 | -$1.19M derived: sum of 3 quarters · filed 2020-05-15 | -$1.18M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | -$684.91K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$680.03K derived: sum of 2 quarters · filed 2020-03-30 | -$670.53K derived: sum of 3 quarters · filed 2020-03-30 | -$647.39K 10-K · filed 2020-03-30 | -$647.61K 10-K · filed 2019-03-15 | ||
| 2018-09-30 | $4.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $14.38K derived: sum of 2 quarters · filed 2019-11-14 | $37.52K 10-Q · filed 2019-11-14 | $0.00 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | $9.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $32.64K 10-Q · filed 2019-08-14 | -$68.97M derived: sum of 3 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $23.13K 10-Q · filed 2019-05-15 | -$68.98M derived: sum of 2 quarters · filed 2019-05-15 | |||||
| 2017-12-31 | -$69.00M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |